scholarly journals Perspectives of Cell Therapy in Type 1 Diabetes

10.5772/22261 ◽  
2011 ◽  
Author(s):  
Maria M. ◽  
Vincenzo Cantaluppi ◽  
Enrica Favaro ◽  
Elisa Camussi ◽  
Maria Chiara ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cell Therapy

Cell therapy for type-1 diabetes

2009 ◽  
Vol 3 (6) ◽  
pp. 511-518
Author(s):  
I. B. Sokolova
Keyword(s):  
Type 1 Diabetes ◽  
Cell Therapy

scholarly journals The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes

Cells ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1589
Author(s):  
Ryota Inoue ◽  
Kuniyuki Nishiyama ◽  
Jinghe Li ◽  
Daisuke Miyashita ◽  
Masato Ono ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Islet Cells ◽  
Autologous Transplantation ◽  
Insulin Injection ◽  
Islet Cell Transplantation ◽  
The Impact

Stem cell therapy using islet-like insulin-producing cells derived from human pluripotent stem cells has the potential to allow patients with type 1 diabetes to withdraw from insulin therapy. However, several issues exist regarding the use of stem cell therapy to treat type 1 diabetes. In this review, we will focus on the following topics: (1) autoimmune responses during the autologous transplantation of stem cell-derived islet cells, (2) a comparison of stem cell therapy with insulin injection therapy, (3) the impact of the islet microenvironment on stem cell-derived islet cells, and (4) the cost-effectiveness of stem cell-derived islet cell transplantation. Based on these various viewpoints, we will discuss what is required to perform stem cell therapy for patients with type 1 diabetes.

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

2009 ◽  
Vol 35 (2) ◽  
pp. 85-93 ◽  
Author(s):  
L. Vija ◽  
D. Farge ◽  
J.-F. Gautier ◽  
P. Vexiau ◽  
C. Dumitrache ◽  
...  
Keyword(s):  
Stem Cells ◽  
Type 1 Diabetes ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy

Organoid optimization: Engineering a better cell therapy to treat type 1 diabetes

2020 ◽  
Vol 12 (526) ◽  
pp. eaba2909
Author(s):  
Jessica D. Weaver
Keyword(s):  
Type 1 Diabetes ◽  
Cell Therapy ◽  
Diabetic Mice ◽  
Subcutaneous Space ◽  
And Function

Islet organoids reaggregated in endothelialized collagen constructs improve engraftment and function in the subcutaneous space in diabetic mice.

Cell Therapy in Management of Type 1 Diabetes : An Experimental Animal Trial

2013 ◽  
Vol 64 (1-3) ◽  
pp. 41-49
Author(s):  
Gamal Taha El Sayed ◽  
Mohamed Kamal Tawfeek ◽  
Alaa El-Din Ismail Abdel Mottaleb ◽  
Hassan Mostafa Serry ◽  
Marwa Mohamed Ahmed Elsawy
Keyword(s):  
Type 1 Diabetes ◽  
Cell Therapy ◽  
Experimental Animal ◽  
Animal Trial

scholarly journals It's Time to Bring Dendritic Cell Therapy to Type 1 Diabetes

Diabetes ◽  
2013 ◽  
Vol 63 (1) ◽  
pp. 20-30 ◽  
Author(s):  
R. J. Creusot ◽  
N. Giannoukakis ◽  
M. Trucco ◽  
M. J. Clare-Salzler ◽  
C. G. Fathman
Keyword(s):  
Type 1 Diabetes ◽  
Dendritic Cell ◽  
Cell Therapy ◽  
Dendritic Cell Therapy

scholarly journals Stem Cell Therapy in Treating Type 1 Diabetes Mellitus –Potential and Ethical Issues.

2021 ◽  
Author(s):  
Nursuaidah Abdullah ◽  
Marjanu Hikmah Elias
Keyword(s):  
Stem Cells ◽  
Type 1 Diabetes ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Cell Transplant ◽  
Exogenous Insulin ◽  
Hematopoietic Stem ◽  
Wide Range

Type 1 diabetes (T1D) is a deficiency in insulin production which is mainly due to loss of ?-cell pancreatic islets. Patients with T1D need to be given exogenous insulin regularly. While improvements in the delivery of insulin and glucose monitoring methods have been effective in improving patient safety, insulin therapy is not a cure and is often associated with complications and debilitating hypoglycaemic episodes. Meanwhile, pancreas or islet transplantation as a gold standard only promises temporary freedom from exogenous insulin and suffers from issues of its own. Stem cell therapy may provide a more permanent solution, given stem cells’ immunomodulatory characteristics and ability to self-renew and distinguish into specific cells. In this sense, the therapeutic potentials of stem cells are addressed in this study. These stem cells cover a wide range of treatments for T1D including embryonic stem cells, induced pluripotent stem cells, bone-marrow derived hematopoietic stem cells and multipotent mesenchymal stromal cells. The challenges faced by the current stem cell transplant in T1D treatment and Islamic viewpoints regarding ethics in stem cell research and therapy are also discussed. In conclusion, stem cell therapy offers a safe and efficient alternative treatment for T1D. However, besides the fatwa from Fatwa Committee of Selangor, the lack of Malaysian stem cells ethics should be further addressed.

scholarly journals Polyclonal Anti-T-Cell Therapy for Type 1 Diabetes Mellitus of Recent Onset

2004 ◽  
Vol 1 (2) ◽  
pp. 80-80 ◽  
Author(s):  
Frantisek Saudek ◽  
Tereza Havrdova ◽  
Petr Boucek ◽  
Ludmila Karasova ◽  
Peter Novota ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
T Cell ◽  
Cell Therapy ◽  
Type 1 Diabetes Mellitus ◽  
T Cell Therapy ◽  
Recent Onset
Sign in / Sign up

Export Citation Format

Share Document